Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy

被引:0
|
作者
Daniel, J. [1 ]
Fioravanti, V. [1 ]
Fischer, R. [1 ]
Hendrickson, R. [1 ]
Ricks, S. [1 ]
Davis, M. [1 ]
Andrews, W. [1 ]
机构
[1] Univ Missouri, Childrens Mercy Hosp, Kansas City, MO 64108 USA
关键词
D O I
10.1097/00007890-201407151-00713
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A491
引用
收藏
页码:239 / 240
页数:2
相关论文
共 50 条
  • [1] Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy
    Daniel, J.
    Fioravanti, V.
    Fischer, R.
    Hendrickson, R.
    Ricks, S.
    Davis, M.
    Andrews, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 239 - 240
  • [2] Indications and Efficacy of Converting From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma
    Hendrickson, R.
    Daniel, J.
    Andrews, W.
    Fischer, R.
    Manalang, M.
    Ricks, S.
    [J]. TRANSPLANTATION, 2014, 98 : 721 - 721
  • [3] Indications and Efficacy of Converting From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma.
    Hendrickson, R.
    Daniel, J.
    Andrews, W.
    Fischer, R.
    Manalang, M.
    Ricks, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 721 - 721
  • [4] Comparison of tacrolimus(TAC) and sirolimus(SLR) versus cyclosporine(CSA) and SLR in kidney transplant recipients maintained on steroid free immunosuppression.
    Saeed, MI
    Kumar, MSA
    Heifets, M
    Sierka, D
    Xiao, SG
    Moritz, MJ
    Parikh, MH
    Fyfe, B
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 218 - 218
  • [5] Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
    Bakhtiari, H.
    Todd, S.
    Snyder, H.
    Lo, D.
    Flynn, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 759 - 759
  • [6] A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients
    Yu, Si
    He, Xiaoshun
    Yang, Lu
    Ma, Yi
    Zhu, Xiaofeng
    Ju, Weiqiang
    Huang, Jiefu
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2008, 6 (02) : 113 - 117
  • [7] Use of sirolimus rescue therapy in pediatric liver transplant recipients with tacrolimus-based immunosuppression.
    Kato, T
    Pinna, AD
    Weppler, D
    Gonzalez, ML
    Mittal, N
    Khan, FA
    Nery, JR
    Tzakis, AG
    [J]. TRANSPLANTATION, 2000, 69 (08) : S165 - S165
  • [8] Indications and efficacy of conversion from tacrolimus- to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma
    Hendrickson, Richard J.
    Sujka, Joseph
    Fischer, Ryan
    Manalang, Michelle
    Daniel, James
    Andrews, Walter S.
    [J]. PEDIATRIC TRANSPLANTATION, 2019, 23 (03)
  • [9] Conversion from Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Patients Who Underwent Liver Transplantation for Unresectable Hepatoblastoma-2 Year Follow-Up
    Hendrickson, R.
    Andrews, W.
    Davis, M.
    Cisneros, R.
    Fischer, R.
    Daniel, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 767 - 767
  • [10] IMMUNOREGULATORY EFFECTS OF CONVERSION FROM TACROLIMUS TO SIROLIMUS IN LIVER TRANSPLANT RECIPIENTS
    Levitsky, Josh
    Mathew, James M.
    Flaa, Catherine W.
    Rosen, Anne
    Tambur, Anat R.
    Miller, Joshua
    [J]. HEPATOLOGY, 2009, 50 (04) : 568A - 568A